Delivery Order SPE2DB24D1007-SPE2DB24FCALS
Award Date
9/16/24
Potential Completion Date
10/7/24
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the medication Zeposia 0.92 mg Capsule 30s, with a ceiling value of $13,862.79 and a performance period through May 21, 2025. This contract is not set-aside and was awarded as part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,862.79, is for the delivery of Zeposia 0.92 mg capsules. Zeposia is a medication used to treat certain neurological conditions. The contract is a firm fixed-price, non-set-aside award with a performance period through May 2025. AmerisourceBergen Drug Corp also holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $4,466.57 firm-fixed-price contract is for the supply of the prescription medication Zeposia 0.92 MG Capsule 30S. The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Zeposia 0.92 MG Capsule 30S, a medication, with a ceiling value of $9,241.86 and an ultimate completion date of January 22, 2025. The contract is a firm fixed-price type and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Zeposia 0.92 mg capsules, valued at $8,933.14. This is a firm fixed-price delivery order contract with an ultimate completion date of August 23, 2024. The award does not utilize a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $13,862.79 and an ultimate completion date of June 13, 2025. The contract provides for the delivery of the pharmaceutical product ZEPOSIA 0.92 MG CAPSULE 30S. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order under contract SPE2DB24FJG97, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Zeposia 0.92 MG capsules, a specialty medication. The delivery order has a ceiling value of $26,799.42 and runs through August 9, 2024. AmerisourceBergen, a for-profit organization, was awarded this contract without any set-aside designation. This contract is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of Zeposia 0.92 MG Capsules in 30-count packages, with a ceiling value of $13,399.71 and a completion date of July 5, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This is a delivery order awarded to Amerisourcebergen Drug Corp Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product Zeposia 0.92 mg Capsule 30s. The contract has a ceiling value of $4,466.57 and an ultimate completion date of October 10, 2024. It is a firm fixed-price contract type and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 MG capsules. The order, valued at $13,399.71, has a firm fixed price and a completion date of September 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, is delivering this medication to support various government healthcare programs and facilities, including military treatment facilities and veterans' hospitals. The contract is not set aside for any...